Clinical Trial: Feasibility Study of Physiotherapy for Functional Motor Symptoms
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Randomised Feasibility Study of a Physiotherapy Programme for Patients With Functional Motor Symptoms (FMS).
Brief Summary: The aim of this study is to develop and assess the feasibility of a physiotherapy intervention for people with functional motor symptoms (also known as psychogenic neurological symptoms and conversion disorder). Participants will be randomised to receive the intervention or a "treatment as usual" control.
Detailed Summary:
Participants will be recruited from outpatient neurology clinics at Queen Square. Those who consent to take part will complete baseline outcome measures (Time 1) before being randomised to either a Treatment as Usual control group or the Intervention group.
Treatment as Usual group -
- Participants will be directed to online patient information resources (www.neurosymptoms.org)
- Participants will be placed on the waiting list to be assessed for the inpatient treatment programme for functional symptoms at The National Hospital for Neurology and Neurosurgery. The waitlist is currently greater than 12 months.
- A referral is made to local community therapy services (which may include physiotherapy, occupational therapy and psychological therapy). If the participant has had contact from their community therapy services in the previous 12 months, a letter summarising the participant's diagnosis and physiotherapy needs will be sent.
- Participants will be asked to return at 4 weeks to complete outcome measures for a second time (Time 2)
A referral to community therapy for such patients is usual practice in the UK, although the form in which the community therapy is provided tends to be inconsistent across the UK. In most cases it will entail between 1 and 8 outpatient or domiciliary physiotherapy appointments. Some communities will have access to Occupational Therapy, which may entail supported practice and advice to increase independence with functional tasks and the provision of equipment. The provision of community therapy to participants will be monitored through the CSRI.
Intervention Group
Sponsor: University College, London
Current Primary Outcome: Clinical Global Impression Scale of Change [ Time Frame: Approximately 4 weeks after randomisation (this will be immediately after treatment for the experimental arm) and 6 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Short Form 36 [ Time Frame: Baseline and 6 months ]
- Hospital Anxiety and Depression Scale [ Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months ]
- EQ-5D-5L [ Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months ]
- Brief Illness Perception Questionnaire [ Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months ]
- Work and Social Adjustment Scale [ Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months ]
- Disabilities of the Arm, Shoulder and Hand (DASH) [ Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months ]self reported questionnaire of upper limb function
- Functional Mobility Scale [ Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months ]Scale of assistance required when walking 5, 50 and 500 metres.
- Psychogenic Movement Disorders Rating Scale (PMDRS) [ Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months ]Blind video analysis of movement
- Berg Balance Scale [ Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months ]
- 10 metre Walk Test [ Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months ]timed walk over 10 metres
Original Secondary Outcome: Same as current
Information By: University College, London
Dates:
Date Received: October 20, 2014
Date Started: September 2014
Date Completion:
Last Updated: May 13, 2016
Last Verified: May 2015
